Myovant Sciences Gmbh

Palatin Technologies Incorporated

Cosette Pharmaceuticals, Inc.

Laura Ann Williams

Vijaykumar Reddy Rajasekhar

Brendan Mark Johnson

Julie Krop

The present invention relates to formulations and methods for treatment of sexual dysfunction in females diagnosed with both sexual dysfunction and controlled hypertension.

Use of bremelanotide in patients with controlled hypertension

Further according to the present disclosure, there are methods for promoting egg maturation in assisted reproductive technologies, such as in in vitro fertilization (IVF) or in an embryo transfer (ET) process. There are also methods for decreasing the rate of ovarian hyperstimulation syndrome (OHSS), providing comparable or improved pregnancy rates, decreasing the time to pregnancy, and inhibiting premature ovulation. The methods include the step of administering a therapeutically effective amount of an active pharmaceutical ingredient of 2-(N-acetyl-D-tyrosyl-trans-4-hydroxy-L-prolyl-L-asparaginyl-L-threonyl-L-phenylalanyl) hydrazinocarbonyl-L-leucyl-N&#x3c9;-methyl-L-arginyl-L-tryptophanamide or a pharmaceutically acceptable salt thereof.

Growing community of inventors

Sudbury, MA, United States of America

Laura Ann Williams